POINT Biopharma Provides Early-Stage Program Updates
Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for...
Month: February 2022
Veru Reports that Independent Data Monitoring Committee for the Phase 3 Sabizabulin COVID-19 Clinical Study Recommends Continuing Study as Planned
--Planned Conditional Statistical Power Analysis was Conducted— --Primary Efficacy Study Endpoint Is Proportion of Patients that Die on Study Up...
Albireo Announces Publication of the PICTURE Study Highlighting the Caregiver Impact of PFIC, a Rare and Devastating Children’s Liver Disease
PFIC caregivers reported high impact on mental and physical health, productivity, career prospects, sleep, relationships and financesStudy suggests PFIC caregivers’...
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104
ANAHEIM, CA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Britannia to Launch Hair Growth Trial Utilizing CBD Formulation
London, United Kingdom and Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia"), a...
Green Shield Canada’s Claim Watch to Participate in Data Pooling to Reduce Benefits Fraud
Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Green Shield Canada (GSC),and its Claim Watch fraud investigation team are joining...
Forbes Names Philips a Top Place to Work in “America’s Best Employers of 2022” Ranking
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has once...
PriorAuthNow Raises $25 Million to Expedite Healthcare Authorizations
Funding round is led by Insight Partners to accelerate growth and fuel platform’s network expansion to meet surging demand COLUMBUS,...
Imperative Care Announces the Launch of Its Zoom POD™ for Stroke Treatment, the First and Only Filter to Capture Clot in the Sterile Field
Newest addition to company’s Zoom Stroke Solution allows for quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic...
450 of the Latest Dosell Produced and Delivered to Partners
STOCKHOLM, SWEDEN / ACCESSWIRE / February 14, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - announces that since the...
AB Science – Clarification following the February 11, 2022 public hearing of the Enforcement Committee of the French Market Regulator (AMF)
PRESS RELEASE CLARIFICATION FOLLOWING THE FEBRUARY 11, 2022 PUBLIC HEARING OF THE ENFORCEMENT COMMITTEE OF THE FRENCH MARKET REGULATOR (AMF)...
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a...
Boosh Acquires Beanfields
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or...
Canadian School Counselling Week 2022: Who We Are and How We Help
Ottawa, Ontario--(Newsfile Corp. - February 11, 2022) - As students across Canada return to in-person schooling during another school year...
NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference
ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
After Three Years of Record Growth, Beam Continues Expansion with First Chief Product Officer
Fintech and digital health veteran brings two decades of experience building and scaling digital products.COLUMBUS, Ohio, Feb. 11, 2022 (GLOBE...
NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION
NFL LEGEND BRETT FAVRE INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION NFL LEGEND BRETT FAVRE NFL LEGEND...
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
CHARLOTTESVILLE, Va., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Amolyt Pharma to Participate at Three Upcoming Investor Conferences
LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic...